| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9870 | 
      | Human Intestinal Absorption | HIA+ | 0.9718 | 
      | Caco-2 Permeability | Caco2+ | 0.8813 | 
      | P-glycoprotein Substrate | Substrate | 0.7933 | 
      | P-glycoprotein Inhibitor | Inhibitor | 0.6857 | 
                                                     | Inhibitor | 0.6352 | 
      | Renal Organic Cation Transporter | Inhibitor | 0.7561 | 
        
            | Distribution | 
        
      | Subcellular localization | Lysosome | 0.3811 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7526 | 
      | CYP450 2D6 Substrate | Substrate | 0.9334 | 
      | CYP450 3A4 Substrate | Substrate | 0.5578 | 
      | CYP450 1A2 Inhibitor | Inhibitor | 0.8935 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9483 | 
        | CYP450 2D6 Inhibitor | Inhibitor | 0.9622 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.7980 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9166 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6784 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9662 | 
                                                                    | Inhibitor | 0.7828 | 
      | AMES Toxicity | Non AMES toxic | 0.9176 | 
      | Carcinogens | Non-carcinogens | 0.9545 | 
      | Fish Toxicity | High FHMT | 0.8253 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.7974 | 
      | Honey Bee Toxicity | Low HBT | 0.7660 | 
      | Biodegradation | Not ready biodegradable | 0.9921 | 
      | Acute Oral Toxicity | II | 0.7604 | 
      | Carcinogenicity (Three-class) | Non-required | 0.7464 |